Saltar al contenido
MilliporeSigma

Y0000731

Felbinac

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

4-Biphenylacetic acid

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

10 MG

$136.00

$136.00

Precio de catálogo$170.00Ahorre 20 %

Comprobar disponibilidad del carrito

Solicite una orden a granel

Acerca de este artículo

Fórmula lineal:
C6H5C6H4CH2CO2H
Número CAS:
Peso molecular:
212.24
NACRES:
NA.24
PubChem Substance ID:
UNSPSC Code:
41116107
MDL number:

Saltar a

Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Nombre del producto

Felbinac, European Pharmacopoeia (EP) Reference Standard

InChI

1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)

SMILES string

OC(=O)Cc1ccc(cc1)-c2ccccc2

InChI key

QRZAKQDHEVVFRX-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

felbinac

manufacturer/tradename

EDQM

mp

159-160 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

¿Está buscando productos similares? Visita Guía de comparación de productos

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo
BP620Y0000732F0041000
Felbinac European Pharmacopoeia (EP) Reference Standard

Y0000731

Felbinac

Felbinac British Pharmacopoeia (BP) Reference Standard

BP620

Felbinac

Fenbufen European Pharmacopoeia (EP) Reference Standard

F0041000

Fenbufen

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

manufacturer/tradename

EDQM

manufacturer/tradename

BP

manufacturer/tradename

EDQM

manufacturer/tradename

EDQM

format

neat

format

neat

format

neat

format

neat

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical
pharmaceutical small molecule

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

API family

felbinac

API family

felbinac

API family

felbinac

API family

fenbufen

mp

159-160 °C (lit.)

mp

159-160 °C (lit.)

mp

116-118 °C (lit.)

mp

184-187 °C (lit.)

Application

Felbinac EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

related product

Referencia del producto
Descripción
Precios

pictograms

Skull and crossbones

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Clase de almacenamiento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

G Hosie et al.
European journal of rheumatology and inflammation, 14(4), 21-28 (1994-01-01)
Musculoskeletal disorders such as soft tissue injuries have traditionally been treated with oral NSAIDs, despite the significant side-effects associated with their clinical use. However, four separate multicentre, double-blind, double-dummy clinical trials have shown that the efficacy of the topical NSAID
Georges E Janssens et al.
Cell reports, 27(2), 467-480 (2019-04-11)
Aging strongly influences human morbidity and mortality. Thus, aging-preventive compounds could greatly improve our health and lifespan. Here we screened for such compounds, known as geroprotectors, employing the power of transcriptomics to predict biological age. Using age-stratified human tissue transcriptomes
Yogita Bansal et al.
Archives of pharmacal research, 37(11), 1426-1436 (2013-11-06)
Polyfunctional compounds comprise a novel class of therapeutic agents for treatment of multifactorial diseases. The present study reports a series of benzimidazole-non-steroidal anti-inflammatory drugs (NSAIDs) conjugates (1-10) as novel polyfunctional compounds synthesized in the presence of orthophosphoric acid. The compounds

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico